| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0049 | 1 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.018 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0038 | 1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |